Fluorouracil News and Research

RSS
Fluorouracil is a drug used to treat symptoms of cancer of the colon, breast, stomach, and pancreas. It is also used in a cream to treat certain skin conditions. Fluorouracil stops cells from making DNA and it may kill cancer cells. It is a type of antimetabolite. Also called 5-fluorouracil and 5-FU.
Spectrum submits FUSILEV sNDA for treatment of colorectal cancer

Spectrum submits FUSILEV sNDA for treatment of colorectal cancer

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Taiho receives CHMP positive opinion on Teysuno in combination with cisplatin for advanced gastric cancer

Taiho receives CHMP positive opinion on Teysuno in combination with cisplatin for advanced gastric cancer

New standard treatment for early stage breast cancer

New standard treatment for early stage breast cancer

Spectrum's FUSILEV sNDA accepted by FDA for review

Spectrum's FUSILEV sNDA accepted by FDA for review

AVEO announces results from tivozanib Phase 1b clinical trial for advanced gastrointestinal cancers

AVEO announces results from tivozanib Phase 1b clinical trial for advanced gastrointestinal cancers

Study demonstrates potent anticancer properties of quinoxalinyl-piperazine compounds

Study demonstrates potent anticancer properties of quinoxalinyl-piperazine compounds

Spectrum submits complete response to FDA's CRL for FUSILEV to treat colorectal cancer

Spectrum submits complete response to FDA's CRL for FUSILEV to treat colorectal cancer

Novel small molecule inhibitors may provide new therapy for colon cancer

Novel small molecule inhibitors may provide new therapy for colon cancer

FDA approves Herceptin with chemotherapy for HER2-positive metastatic cancer

FDA approves Herceptin with chemotherapy for HER2-positive metastatic cancer

Amgen to present oncology portfolio results at ESMO Congress

Amgen to present oncology portfolio results at ESMO Congress

Amgen announces PRIME '203' and '181' Phase 3 trial results

Amgen announces PRIME '203' and '181' Phase 3 trial results

Researchers discover treatment improves overall survival in pregnant women with breast cancer

Researchers discover treatment improves overall survival in pregnant women with breast cancer

Study: Capecitabine with concurrent radiation is effective for treating gastric cancer

Study: Capecitabine with concurrent radiation is effective for treating gastric cancer

Aflibercept Phase 3 VELOUR clinical trial for mCRC to continue to completion

Aflibercept Phase 3 VELOUR clinical trial for mCRC to continue to completion

Gemcitabine does not improve survival compared with fluorouracil plus folinic acid in resected pancreatic cancer

Gemcitabine does not improve survival compared with fluorouracil plus folinic acid in resected pancreatic cancer

ESPAC-3 trial shows promising results to prevent pancreatic cancer

ESPAC-3 trial shows promising results to prevent pancreatic cancer

Merck's initiation of IMO-2055 Phase 1b clinical trial in SCCHN triggers €3.0M milestone payment to Idera

Merck's initiation of IMO-2055 Phase 1b clinical trial in SCCHN triggers €3.0M milestone payment to Idera

Trial shows positive results for radioembolisation technique for colorectal cancer liver metastases treatment

Trial shows positive results for radioembolisation technique for colorectal cancer liver metastases treatment

Amgen reports top-line results from Vectibix Phase 3 trial for head and neck cancer

Amgen reports top-line results from Vectibix Phase 3 trial for head and neck cancer